UNIQURE ($QURE) posted quarterly earnings results for Q4 2025 on Monday, March 2nd. The company reported earnings of -$0.56 per share, beating estimates of -$0.97 by $0.41. The company also reported revenue of $5,570,000, beating estimates of $5,308,161 by $261,839.
You can see Quiver Quantitative's $QURE stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
UNIQURE Insider Trading Activity
UNIQURE insiders have traded $QURE stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $QURE stock by insiders over the last 6 months:
- MATTHEW C KAPUSTA (CEO, Managing Director) has made 0 purchases and 6 sales selling 238,694 shares for an estimated $9,677,811.
- ROBERT GUT has made 0 purchases and 5 sales selling 57,047 shares for an estimated $1,487,364.
- JACK KAYE has made 0 purchases and 4 sales selling 45,200 shares for an estimated $1,351,836.
- CHRISTIAN KLEMT (Chief Financial Officer) has made 0 purchases and 3 sales selling 24,217 shares for an estimated $1,093,457.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
UNIQURE Hedge Fund Activity
We have seen 136 institutional investors add shares of UNIQURE stock to their portfolio, and 138 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ECOR1 CAPITAL, LLC removed 3,988,971 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $95,456,076
- STATE STREET CORP added 1,787,033 shares (+123.8%) to their portfolio in Q4 2025, for an estimated $42,763,699
- JPMORGAN CHASE & CO added 1,785,275 shares (+155.3%) to their portfolio in Q4 2025, for an estimated $42,721,630
- AVORO CAPITAL ADVISORS LLC added 1,705,556 shares (+38.4%) to their portfolio in Q4 2025, for an estimated $40,813,955
- RTW INVESTMENTS, LP removed 1,446,769 shares (-28.0%) from their portfolio in Q4 2025, for an estimated $34,621,182
- MPM BIOIMPACT LLC added 1,381,628 shares (+inf%) to their portfolio in Q4 2025, for an estimated $33,062,358
- FRANKLIN RESOURCES INC removed 1,241,979 shares (-62.5%) from their portfolio in Q4 2025, for an estimated $29,720,557
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
UNIQURE Analyst Ratings
Wall Street analysts have issued reports on $QURE in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 12/11/2025
- Mizuho issued a "Outperform" rating on 12/09/2025
- Wells Fargo issued a "Overweight" rating on 11/12/2025
- Leerink Partners issued a "Outperform" rating on 11/10/2025
- RBC Capital issued a "Outperform" rating on 11/04/2025
- HC Wainwright & Co. issued a "Buy" rating on 11/04/2025
- Chardan Capital issued a "Buy" rating on 11/03/2025
To track analyst ratings and price targets for UNIQURE, check out Quiver Quantitative's $QURE forecast page.
UNIQURE Price Targets
Multiple analysts have issued price targets for $QURE recently. We have seen 11 analysts offer price targets for $QURE in the last 6 months, with a median target of $53.0.
Here are some recent targets:
- Patrick R. Trucchio from HC Wainwright & Co. set a target price of $70.0 on 02/10/2026
- Eliana Merle from Barclays set a target price of $31.0 on 01/28/2026
- Paul Matteis from Stifel set a target price of $40.0 on 12/11/2025
- Uy Ear from Mizuho set a target price of $33.0 on 12/09/2025
- Daniil Gataulin from Chardan Capital set a target price of $53.0 on 12/04/2025
- Yanan Zhu from Wells Fargo set a target price of $60.0 on 11/12/2025
- Joseph Schwartz from Leerink Partners set a target price of $60.0 on 11/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
